Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 984 | 976 | 876 | 998 | 1146 | 1502 |
| Fund Return | -1.58% | -2.41% | -12.36% | -0.06% | 2.77% | 4.15% |
| Place in category | 492 | 597 | 644 | 443 | 216 | 118 |
| % in Category | 62 | 65 | 80 | 67 | 43 | 38 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| JPI Global Income Fund A mth USD he | 16.84B | 4.29 | 7.45 | 4.13 | ||
| JPI Global Income Fund C acc USD he | 16.84B | 4.65 | 8.18 | 4.84 | ||
| JPI Global Income Fund C dist USD h | 16.84B | 4.64 | 8.17 | 4.83 | ||
| JPI Global Income Fund C mth USD he | 16.84B | 4.64 | 8.18 | 4.84 | ||
| JPI Global Income Fund D acc USD he | 16.84B | 4.12 | 7.09 | 3.78 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| World Healthscience Fund E2 | 2B | -1.37 | 1.41 | 5.00 | ||
| LU1960219225 | 1.32B | -0.51 | 2.93 | - | ||
| LU2112291526 | 670.45M | -1.12 | 1.90 | - | ||
| World Healthscience Fund C2u | 372.97M | -1.81 | 0.65 | 4.21 | ||
| World Healthscience Fund D2u | 1.09B | -0.66 | 2.69 | 6.32 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Eli Lilly | US5324571083 | 8.02 | 703.21 | +0.74% | |
| AbbVie | US00287Y1091 | 6.76 | 206.19 | -0.18% | |
| J&J | US4781601046 | 6.65 | 177.80 | +0.88% | |
| UnitedHealth | US91324P1021 | 4.91 | 304.24 | -1.38% | |
| AstraZeneca | GB0009895292 | 4.78 | 11,782.0 | +0.37% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review